MacroGenics reported $1.53M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
Biogen USD 31.6M 700K Sep/2025
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Genmab DKK 25M 8M Jun/2025
Geron USD 4.26M 392K Sep/2025
Gilead Sciences USD 95M 7M Dec/2025
J&J USD 2.14 237M Mar/2026
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Xencor USD 6.54M 710K Sep/2025